Literature DB >> 33734849

Use of Cannabis for Harm Reduction Among People at High Risk for Overdose in Vancouver, Canada (2016-2018).

Janice Mok1, M-J Milloy1, Cameron Grant1, Stephanie Lake1, Kora DeBeck1, Kanna Hayashi1, M Eugenia Socías1.   

Abstract

Objectives. To characterize the prevalence and reasons for the use of cannabis as a strategy to reduce the harms arising from other substances.Methods. We drew data about recent cannabis use and intentions from 3 prospective cohort studies of marginalized people who use drugs based in Vancouver, Canada, from June 2016 to May 2018. The primary outcome was "use of cannabis for harm reduction," defined as using cannabis for substitution for licit or illicit substances such as heroin or other opioids, cocaine, methamphetamine, or alcohol; treating withdrawal; or coming down off other drugs.Results. Approximately 1 in 4 participants reported using cannabis for harm reduction at least once during the study period. The most frequent reasons included substituting for stimulants (50%) and substituting for illicit opioids (31%).Conclusions. The use of cannabis for harm reduction is a common strategy among people who use drugs in our setting. Further research into the factors associated with this strategy is needed. Better characterization of the risks and benefits of substitution strategies, including for opioids and stimulants, may prompt new treatment options for PWUD.

Entities:  

Mesh:

Year:  2021        PMID: 33734849      PMCID: PMC8033988          DOI: 10.2105/AJPH.2021.306168

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.

Authors:  Marcus A Bachhuber; Brendan Saloner; Chinazo O Cunningham; Colleen L Barry
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

Review 2.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

3.  Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada.

Authors:  Benedikt Fischer; Wayne Jones; Wayne Hall; Paul Kurdyak
Journal:  Int J Drug Policy       Date:  2019-08-10

Review 4.  Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.

Authors:  Brian Chan; Michele Freeman; Karli Kondo; Chelsea Ayers; Jessica Montgomery; Robin Paynter; Devan Kansagara
Journal:  Addiction       Date:  2019-09-12       Impact factor: 6.526

5.  Cannabis research data reveals a focus on harms of the drug.

Authors:  Cathleen O'Grady
Journal:  Science       Date:  2020-09-04       Impact factor: 47.728

6.  Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis.

Authors:  M Eugenia Socías; Thomas Kerr; Evan Wood; Huiru Dong; Stephanie Lake; Kanna Hayashi; Kora DeBeck; Didier Jutras-Aswad; Julio Montaner; M-J Milloy
Journal:  Addict Behav       Date:  2017-04-04       Impact factor: 3.913

Review 7.  Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Authors:  Yasmin L Hurd; Michelle Yoon; Alex F Manini; Stephanie Hernandez; Ruben Olmedo; Maria Ostman; Didier Jutras-Aswad
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

8.  Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: a qualitative study.

Authors:  Janaina R Gonçalves; Solange A Nappo
Journal:  BMC Public Health       Date:  2015-07-25       Impact factor: 3.295

9.  "Something that actually works": Cannabis use among young people in the context of street entrenchment.

Authors:  Braedon Paul; Madison Thulien; Rod Knight; M J Milloy; Ben Howard; Scarlett Nelson; Danya Fast
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

10.  Characterizing motivations for cannabis use in a cohort of people who use illicit drugs: A latent class analysis.

Authors:  Stephanie Lake; Ekaterina Nosova; Jane Buxton; Zach Walsh; M Eugenia Socías; Kanna Hayashi; Thomas Kerr; M J Milloy
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.